Added to YB: 2019-08-01
Pitch date: 2019-08-01
ESPR:US [bullish]
Esperion Therapeutics, Inc.
-91.84%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.
Market Cap
$813.5M
Pitch Price
$38.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
15.32
P/E
-94.37
EV/Sales
2.87
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Esperion Therapeutics Inc ESPR:US
A summary for this pitch has not been created yet.
Read full article (0 min)